39+
Years of excellence
10+
Regulator-approved facilities
50+
Countries served
70+
Commercial APIs
Our core services
From early development to commercial supply, Shilpa provides fully integrated pharmaceutical solutions — combining deep scientific expertise, robust quality systems and global regulatory experience.
All capabilities70+ commercial APIs across oncology, immunology, neurology, cardiovascular, respiratory and specialty therapeutic areas.
Oral solids, sterile injectables, oral dissolving films, transdermal patches, oral suspensions, topicals and novel drug delivery.
EU-GMP certified biologics campus at Dharwad, spanning cell line development through to fill-finish.
End-to-end contract development and manufacturing across small molecules, peptides, complex dosage forms and biologics.
Since 1987
39+
Years of pharmaceutical excellence
Since 1987, Shilpa Medicare has evolved from a single API facility in Raichur, Karnataka into a diversified pharmaceutical company with integrated strengths across development, manufacturing and commercialisation.
Our storySupplying APIs, formulations and oncology products to 50+ markets worldwide.
US FDA, EU GMP and other global health authority approvals underpin our quality systems.
Four dedicated R&D centres driving innovation in APIs, formulations, biologics and novel delivery platforms.
Research & development
Our R&D centres focus on complex generics, oncology APIs, biologics, peptides and advanced delivery systems. By combining deep chemistry, biology and engineering capabilities, we bring difficult-to-make products to market faster — without compromising on quality or patient safety.
Focus areas
Global accreditations
Our facilities are inspected by leading global health authorities, reflecting our commitment to quality and compliance.
Quality management certifications
Newsroom
Milestones that showcase our commitment to pharmaceutical innovation and excellence.
CDSCO Approval
Received approval for Hemostatic Spray, expanding our specialised product portfolio.
UK MHRA Certificate
GMP Certificate issued by UK MHRA for our Dabaspet manufacturing facility.
Export Excellence Award
Best District Export Excellence Award recognising our global market contribution.
FAQ
Can’t find what you’re looking for? Our business development team will get back to you within two working days.
We develop and manufacture active pharmaceutical ingredients, complex finished dosage forms and biologics, and offer end-to-end CDMO services — from early development to commercial supply.
Our facilities are inspected by leading global health authorities including USFDA, EDQM, EU GMP, Health Canada, ANVISA, TGA and WHO GMP, and we hold a GMP certificate from UK MHRA for our Dabaspet site.
Yes. We operate high-containment suites for cytotoxic and high-potency molecules with HPAPI capabilities across OEL 1–5.
Our API sites are in Raichur, Karnataka, our EU-GMP certified biologics campus is in Dharwad, and our formulations facility is at Dabaspet.
Send us a short brief through the contact page. Our business development team will set up a confidential discussion, typically under an NDA.
Talk to our team about APIs, complex formulations, biologics or a CDMO programme.
